Abstract: Severe Oxidative stress
INTRODUCTION
An alarming epidemic of tuberculosis has followed the rapid rise in HIV/AIDS cases particularly in developing countries such as Nigeria. Tuberculosis (TB) is the leading infectious killer of people living with HIV and accounted for an estimated 13% of Acquired Immune Deficiency Syndrome (AIDS) death worldwide (Sharma et al., 2005) . HIV and TB are so often closely connected that they are often referred to as co-epidemics or dual epidemics. HIV activates dormant TB in a person who then becomes infectious and able to spread TB bacilli to others (UNAIDS, 2010) . Th1 type immune response characterized by adequate cell mediated immunity is the crucial host defense against Mycobacterium Tuberculosis (Schluger and Rom, 1998) . HIV infection primarily affects those components of host immune response responsible for cell mediated immunity. Thus in HIV infected individuals with latent tuberculosis, the fine balance between Mycobacterium tuberculosis and positive HIV test. Before recruiting of participants for this the host immunity is lost favouring reactivation of latent research at the VCT, they were screened for HIV infection TB (FitzGerald and Houston, 1991) .
and Mycobacterum tuberculosis infection. The Oxidative stress has emerged in recent years as a participants who were HIV seropositive were further suspected component in the pathogenesis of HIV grouped into asymptomatic HIV stage 1 and disease (Carole and Sterrit, 1994) . Increasing number symptomatic HIV stage 2, 3 and 4 using the World of reports have shown that even in the earliest stages of Health Organization (WHO) guidelines for HIV disease infection, a deleterious reductive-oxidative (redox) staging. Stages 1, 3 and 4 individuals were excluded imbalance may occur, this means that increased from the present study. Control group consisted o f reactive oxygen intermediates are generated at the participants who were HIV seronegative with or without same time that stores of naturally occurring reducing tuberculosis infection. The recruited participants were agents are depleted. The possible result is the not on Anti Retro viral Therapy (ART) and TB therapy. uncontrolled presence of oxygen-containing molecules Based on the above criteria, the participants were which may overwhelm the antioxidant capacity and grouped as follows: cause damage to cell membranes, protein and nucleic acids and also cause alterations in the intra and inter-C Symptomatic HIV stage 2 aged 39±18 (n = 112, M = cellular environment (Carole and Sterrit, 1994) .
43, F = 69): Symptomatic HIV stage 2 with Mycobacteria are intracellular pathogens that grow and tuberculosis co-infections (n = 67). Symptomatic HIV replicate in the host macrophages. In an attempt to kill stage 2 infected without tuberculosis (n = 45) mycobacterium, host cells namely macrophages, C Similarly the Control Subjects consisted of HIV neutrophils and monocytes generate huge amount of seronegative participants aged 38±19 years (n = 81 reactive oxygen species which contribute to inflammatory M = 36, F = 45): HIV seronegative participants with injury to host tissues and may further lead t o Tuberculosis (n=52), HIV seronegative participants immunosuppression particularly in those with impaired without Tuberculosis (n = 29) antioxidant capacity such as HIV infected individuals. Moreover the malnutrition which is commonly present in Blood sample collection: 6ml of blood sample was patients with tuberculosis can add to the impaired collected from each participant and dispensed into antioxidant capacity in these patients (Kauri et al., 2005) . lithium heparinized container for Glutathione peroxidase Therefore TB and HIV infections lead to continuous enzyme activity, plain tubes for total antioxidant status, production of free radicals that may cause a resultant glutathione reductase using spectrophotometric method low level of antioxidants (Wiid et al., 2004) .
respectively and serum albumin measurement b y Albumin is an important component of plasma with Bromo Cresol Green (BCG) method and the remaining antioxidant activity that primarily binds free fatty acids, into EDTA container for HIV screening using divalent cations and hydrogen peroxides. The Serum immunoassay and immunochromatography method albumin is an important index of the nutritional status of and CD4+T-cell count by Cyflow. an individual. In an advanced HIV/AIDS and TB, albumin Also three early morning sputum specimen were concentration may be reduced due to reduced intake collected from each of the participants for three resulting from loss of appetite and reduced hepatic consecutive days for Zeihl-Neelson staining for acid fast synthesis (Yamanaka et al., 2001) .
bacilli. Therefore, examination of antioxidants in participants Informed consent was obtained from those who with HIV and tuberculosis infections may identify participated in the study. The Nnamdi Azikiwe University deficiencies that predispose to severe oxidant injury and Teaching Hospital Board of Ethical Committee approved immunodeficiency. However our knowledge of the the study design. antioxidant profile in HIV patients with or without TB is scarce particularly in developing countries. Thus t o HIV s creening were by both immunoassay and further study the interaction between HIV, TB and immunochromatographic methods antioxidants we investigated antioxidant status and its
Immunoassay method: HIV screening was performed relationship to CD4+T cell count and albumin in HIV and using Abbot determine HIV-1 and 2 kit. (Abbot Japan TB co-infected participants.
Co ltd. Tokyo, Japan). The procedure was as described . This method utilizes immobilized antigen for the detection o f antibodies to HIV 1 and 2 in the human plasma. The procedure was as described by the manufacturer of the kit. In brief, 50µl of plasma sample was dispensed into appropriately labeled sample wells, then three drops of running buffer was added drop-wise into the appropriately labeled sample wells. The results of the test were read at 10 minutes after the addition of the running buffer. This method had inherent quality control that validates the results. The presence of two pink lines in the region of test sample and control indicates HIV seropositive reaction while a single pink line at the control region indicates HIV seronegative reaction. HIV seropositive results using these two methods were used to confirm participants presenting with HIV infection. Determination of CD4+T cell count by Cyflow (Germany) 50µl of whole blood in EDTA anti-coagulant was dispensed into a partec test tube and 10 µl of CD4 PE antibody was added. The reaction mixture was incubated in the dark for 10-15 minutes. After incubation, 800 µl of the already prepared diluted buffer (Xn 0.09% NaN3) was added to each reaction tube and vortexed. The partec tubes containing these reactions were plugged in position in the Cyflow SL Green (Partec Germany) which has already been connected to flow max software, CD4 count template data file and CD4 count instrument. The test was run on the Cyflow for 90 seconds. The results were displayed as histogram and printed. The CD4+T-Cell count was read off the histogram correcting for the dilution factor.
MATERIALS AND METHODS

Subjects
Determination of Glutathione peroxidase enzyme:
The procedure was as described by the manufacturer of the kit (Randox Laboratories Ltd, UK). In brief, 0.05 ml of heparinized whole blood from each of the participant was put in appropriately labeled test tubes containing 1ml of diluting agent (0.18 mmol/L). This was incubated for 5 minutes. After the incubation, 1ml of haemoglobin reagent (containing I volume o f haemoglobin reagent with 4 volumes redistilled water) was added. This was mixed very well and assayed within 20 minutes for Glutathione peroxidase as follows: 0.02 ml of the diluted sample was added in a labeled separate test tubes containing 1ml of Reagent 1 [Glutathione 4 mmol/l, Glutathione Reductase 0.5U/L and NADPH 0.34 mmol/L in phosphate buffer P 7.2 H (0.05mol/L and EDTA, 4.3 mmol/L)] and 0.04 ml o f Cumene solution (Cumene Hydroxide, 0.18 mmol/L). The reagent blank was prepared similarly with 0.02 ml of distilled water in place of the sample. This was mixed was read at 340nm against air after 1, 2 and 3 minutes. The change in absorbance of both sample and reagent blank was calculated and the concentration o f Glutathione Peroxidase calculated using a factor of 8412 after subtracting the absorbance of blank from that of sample.
Determination of glutathione reductase enzyme: The procedure was as described by the manufacturer of the kit (Randox Laboratories Ltd, UK). 40 µl of serum from each of the participant was put in appropriately labeled test tube containing 1000 µl of substrate (2.2mmol/L Reduced Glutathione in 5ml of 250mmol/L Potassium Phosphate buffer, PH 7.3 and 5mmo/L EDTA) and 200µl NADPH (0.17mmol/L). This was mixed and the initial absorbance was read after 1 minute at 340nm against air. This was read again after 2, 3, 4 and 5 minutes. The change in absorbance was calculated and used t o calculate the Glutathione Reductase activity in U/L by multiplying by a factor of 4983.
Determination of total antioxidant status: This was as described by the manufacturer of the kit (Randox Laboratories Ltd., UK). 20 µl of serum was added into a test tube containing 1000 µl of 2, 2'-Azino-di-[3-ethylbenzthiazoline sulphonate] and 1000 µl o f chromogen (6.1 µmol/L of Metmyoglobin in 10 ml of 80 mmol/L phosphate buffered saline (PH 7.4). Standard tube and reagent blank was prepared in the same way using a standard solution containing (6-hydroxy-2, 5, 7, 8-tetramethylchroman-2-carboxylic acid) and double distilled water respectively. 25 µl hydrogen peroxide was added to all tubes and mixed. The absorbance was read after 3 minutes at 660nm against air at 37°C. The change in absorbance of sample and blank was calculated and used to determine the total antioxidant status.
Determination of serum albumin by Bromocresol Green (BCG):
The procedure used was as described by the manufacturer of the kit (Randox Laboratories Limited UK). Briefly, 10 µl of serum from each participant was added to appropriately labeled test tubes containing 3mls of BCG. The reaction mixture was allowed to stand for 5 minutes at room temperature. For the standard albumin and blank reagent test reactions, similar procedure as explained for sample test was followed except addition of serum sample. The absorbance of samples and standard was read using spectrophotometer at 620 nm wavelength against reagent blank and the concentration of serum albumin in each sample was calculated. Key: Symp = Symptomatic, n= No. of participants, SD = Standard deviation F(P) = Symptomatic HIV with or without tuberculosis and HIV seronegative control with or without tuberculosis compared (using ANOVA) {a} Vs {b} = Symptomatic HIV with tuberculosis compared with symptomatic HIV without tuberculosis (using t-test) {a} Vs {c} = Symptomatic HIV with tuberculosis compared with HIV seronegative control with tuberculosis (using t-test) {a} Vs {d} = Symptomatic HIV with tuberculosis compared with HIV seronegative control without tuberculosis (using t-test) {b} Vs {c} = Symptomatic HIV without tuberculosis compared with HIV seronegative control with tuberculosis (using t-test) {b} Vs {d} = Symptomatic HIV without tuberculosis compared with HIV seronegative control without tuberculosis (using t-test) {c} Vs {d} = HIV seronegative control with tuberculosis compared with HIV seronegative control without tuberculosis (using t-test) a = p value at P>0.05, b = P value at P<0.05, c = P value at P<0.01
significantly reduced in symptomatic HIV with with HIV seronegative control participants without tuberculosis compared with the control participants tuberculosis (P<0.01). There was also significantly with and without tuberculosis (P<0.01 in each case).
reduced total antioxidant status in HIV seronegative Similarly, total antioxidant activity was lowered i n control participants with tuberculosis compared with HIV symptomatic HIV without tuberculosis when compared seronegative control participants without tuberculosis (P<0.01). However, the symptomatic HIV without There was also a significant positive correlation tuberculosis showed similar mean value with HIV between CD4+T cell count and glutathione reductase (r seronegative control with tuberculosis (P>0.05) see = 0.670), glutathione peroxidase (r = 0.553) and TAS (r = Table 1. 0.655) in HIV infected participants without tuberculosis A significant difference in mean (+SD) serum albumin at P<0.01 in each case. Among the HIV seronegative (gldl) was seen amongst symptomatic HIV with control with tuberculosis infection, no significant tuberculosis (2.54±0.37), symptomatic HIV without correlation was found between serum albumin and tuberculosis (3.07±0.24), HIV seronegative control glutathione reductase (r = 0.126), glutathione peroxidase participants with tuberculosis (3.49±0.17) and HIV (r = -0.102) and TAS (r = 0.179). (P>0.05) Table 2 and seronegative control participants without tuberculosis Table 2 shows a significant correlation between CD4+T cell count and glutathione reductase (r = 0.702), glutathione peroxidase (r = 0.693) and TAS (r = 0.593) in symptomatic HIV infected participants with tuberculosis (P<0.01 in each case). A significant correlation was also seen between albumin and glutathione reductase (r = 0.656), glutathione peroxidase (r = 0.546) and TAS (r = 0.622) in symptomatic HIV infected participant with tuberculosis. These values were significant at P<0.01, Table 2 and Fig. 1, 4 and 5.
DISCUSSION
The study documents alterations in the levels o f glutathione reductase, glutathione peroxidase and total antioxidant status in HIV infected participants. The implication of this finding of lowered antioxidant status in HIV infected participants is that their ability to protect against free radical induced stress is compromised. This might predispose the HIV infected participants to internal tissue/cell damage which may also cause nuclear lesions considering the activities of free radicals. This study suggests evidence of oxidative stress and disturbed glutathione metabolism in HIV infected participants. HIV infected participants have been shown to have decreased antioxidant concentrations, disruption in glutathione metabolism and enhanced spontaneous generation of reactive oxygen species (Sundarama et al., 2008) . Lower glutathione reductase activity and oxidative stress in general are known to up regulate inflammatory cytokine activity (Akpotuzor et al., 2007) . Glutathione peroxidase plays an important role in the metabolism of reactive oxygen species as a defense mechanism against oxidative damage by catalyzing the reduction of a variety of hydroperoxidation via glutathione as a reducing substrate. The observations in this study therefore reveal that antioxidant supplementation might have an effect in decreasing oxidative stress in HIV infected individuals. Our results also clearly show that severe antioxidant depletion occurred in HIV seropositive individuals in comparison with controls and this depletion becomes more severe as the disease progresses. This is CD4+T cells secrete (Boom et al., 1991) . This implies antioxidant status in control participants without that tuberculosis co-infection in HIV can lead t o tuberculosis co-infection increased disease burden and severe immune cells and progression of disease (Cole et al., 2005) . Audu et al. (2005) who observed that co-infection with Since the immune system is constantly stimulated in tuberculosis or malaria appeared not to have any impact HIV i nfection and antioxidant level is lower in HIV on the degree of depletion of CD4+T cells in HIV infected seropositive individuals than in control participants as subjects but Sharma et al. (2005) had different observed from the study, adequate intake of antioxidants observation that HIV and tuberculosis have synergistic and phytochemicals is critical in minimizing oxidative interaction, each accelerates progression of the other stress.
and tuberculosis co-infection in HIV leads to higher rate The significantly lower glutathione reductase, of CD4+T cell depletion. glutathione peroxidase, total antioxidant status observed TB is the first sign of immune dysfunction associated in participants presenting with tuberculosis without HIV with HIV infection and active TB is an AIDS defining infection and in symptomatic HIV participants with illness. TB infection is an ever increasing concern for tuberculosis suggests that tuberculosis also exerts a people living with HIV. In some parts of the world, TB is negative impact on antioxidant enzyme activity/status. the leading cause of death of people infected with HIV. This has serious implication in HIV infected participants Indeed the risk of developing active TB disease after TB who are also very susceptible to tuberculosis infection. infection or following an apparent cure for several years, In tuberculosis infection, several factors may contribute increases considerably for people with deficient immune to reduced antioxidant status such as tissue system. It was calculated that in case of HIV co-infection, inflammation and malnutrition. The findings show that in this risk is multiplied 50-300 times (Sylvain et al., 2007) . participants with tuberculosis and HIV co-infection there It has also been established that serum anti BCG is is a severe depression in antioxidant enzymes which mostly impaired by HIV infection even in cases o f may lead to progression of disease since infection by malaria co-infection in endemic areas (Onyenekwe, HIV and/or (Oguntibeju et al., 2010) , with resultant decrease infection primarily affects those components of host in endogenous and nutritional antioxidants as well as immune response responsible for cell-mediated micronutrients. Oxidative stress due to over production immunity. Thus in HIV infected individuals with latent TB of free radicals and antioxidant deficiency causes infection, the fine balance between M. tuberculosis and damage to vital biological macromolecules and organs the host immunity is shifted favouring reactivation of M. and further contributes to disease complications, tuberculosis. However the infection is poorly contained progression and morbidity. Nevertheless, this following reactivation, resulting in widespread combination of enhanced oxidative stress and dissemination causing extrapulmonary disease (Zang decreased concentrations of several antioxidants may et al., 1994) . have important pathogenic consequences in HIV and TB The study shows that albumin concentration was co-infected participants. Oxidative stress has been significantly low in symptomatic HIV infected subjects shown to enhance HIV replication, to induce the with or without tuberculosis co-infection and i n production of inflammatory cytokines (Israel and tuberculosis infected control participants. Albumin is an Gougerot-Pocidalo, 1997) and to promote lymphocyte important component of plasma with antioxidant activity apoptosis (Famularo et al., 1997) and T cell dysfunction that primarily binds free fatty acids, divalent cation and (Aukrust et al., 1995) these effects could therefore contribute to increased viral replication and progression of immunodeficiency in patients dually infected with HIV and TB. Another significant finding in this study was that participants with HIV infection had more depleted levels of CD4+T cells and the rate of CD4+T cell counts decreased more in tuberculosis infected symptomatic HIV participants. CD4+T cells are required for host's resistance to mycobacterium tuberculosis (Barber et al., 2011) and they regulate the protective immune response which follows exposure to mycobacterium tuberculosis by activating macrophages through the cytokines the derangement. Although this is in contrast to the report by hydrogen oxochloride (HOCl). These pro-oxidants attack Aukrust, P., A.M. Svardal, F. Muller, B. Lunden, R.K. the cell membranes thereby causing tissue damage and wasting disease. The low level of albumin may therefore contribute to the complications associated with TB and HIV (Oguntibeju et al., 2010) . This reduction of albumin in HIV infection and in tuberculosis infection may be attributed to negative nitrogen balance, anorexia, malnutrition, malabsorption and increased catabolic activities associated with these diseases. Albumin has been used as a prognostic indicator in HIV disease. Onyenekwe et al. (2008) and Olawumi and Olatunji (2006) in their studies have documented a decrease in serum albumin in HIV infected individuals. Matos and Moreira Lemos (2006) documented that the presence of low albumin levels was strongly and independently associated with in-hospital death due to TB. Since HIV infected subjects with tuberculosis had significantly low albumin, this subgroup may potentially benefit from nutritional intervention. Several studies have revealed that micronutrients supplementation to patients with tuberculosis and HIV improves their health by increasing CD4+T cell count, increasing their weight and improving the efficacy of their drug treatment (Jon et al., 2006) . This study highlights the importance of measuring serum albumin levels in people infected with TB and HIV as an indicator of the prognosis and disease progression. From the study we conclude that the antioxidants glutathione reductase, glutathione peroxidase, total antioxidant status, albumin and CD4+T cell count were significantly reduced in symptomatic HIV infected participants with or without TB as well as in participants infected with TB. This finding suggests possible impairment of antioxidant function leading to oxidative stress in HIV and TB infection. Therefore the study suggests that prediction of severity and monitoring of disease could be performed by determining the CD4+T cell c ount, albumin and antioxidant capacity of HIV infected individuals especially those co-infected with TB. Thus Antioxidant supplementation could sufficiently scavenge free radicals, increase total antioxidant capacity with the potential to reduce disease progression and complications, increase survival and improve the general well being of people living with TB and HIV/AIDS.
